Search Results - tinoush+moulaei

2 Results Sort By:
Modified griffithsin tandemers for enhanced activity and reduced viral aggregation
Abstract: Griffithsin (GRFT) is a lectin with potent antiviral properties that is capable of preventing and treating infections caused by a number of enveloped viruses (including HIV, SARS, HCV, HSV, and Japanese encephalitis) and is currently in clinical development as an anti-HIV microbicide. In addition to its broad antiviral activity, GRFT is stable...
Published: 4/8/2024   |   Inventor(s): Barry O'Keefe, Alexander Wlodawer, Tinoush Moulaei
Keywords(s): ANTIVIRAL, mGRFT tandemers
Category(s): TherapeuticArea > Infectious Disease, Collaboration Sought > Licensing, Application > Therapeutics
Griffithsin-Based Anti-viral Therapeutics with Improved Stability and Solubility
Abstract: Griffithsin is a potent anti-viral protein with activity against HIV, HCV, Sars, HSV 1 & 2 and other viruses.  It is active against HIV and HCV at picomolar concentrations.  Griffithsin is moving into clinical trials as an anti-HIV microbicide. Based on the structure of griffithsin and the necessities of pharmaceutical product development...
Published: 7/16/2024   |   Inventor(s): Barry O'Keefe, Kenneth Palmer, Tinoush Moulaei, Lisa Rohan, Joshua Fuqua, Lindsay Kramzer
Keywords(s): Anti-Viral, cnidarin, Griffithsin, HCV, HIV, HSV, SARS
Category(s): Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics, TherapeuticArea > Infectious Disease